But unlike the case of PrP, injections of pathological TDP-43 does not cause robust propagation of proteinopathy in recipient animals, and does not cause neurodegenerative cellular effects, unless those animals also over-express transgenic human TDP-43 in addition to the endogenous mouse gene9,11. The gene discussed is TARDBP; the disease is proteostasis deficiencies.